Back to Results
First PageMeta Content
Cancer organizations / Aggressive fibromatosis / Tamoxifen / Breast cancer / Management of cancer / Cancer research / Breast cancer treatment / Medicine / Oncology / Ribbon symbolism


National Cancer Institute’s Rare Tumors Initiative Clinical Trials for Desmoid Tumors Shivaani Kummar, MD Abby B. Sandler, Ph.D.
Add to Reading List

Document Date: 2013-10-18 16:04:26


Open Document

File Size: 601,75 KB

Share Result on Facebook

Company

Pharmaceutical Industry Laboratory / PET / /

Event

FDA Phase / /

Facility

Processing Data Managers Social Workers Pharmacists Laboratory / MD Developmental Therapeutics Clinic / /

IndustryTerm

Cancer Treatment / /

MedicalCondition

MPNSTs / tumor / Gynecologic Tumors / plexiform neurofibromas / Endometrial Cancer / desmoids / tumors / Positive Breast Cancer / desmoid tumors / Adults With Desmoid / biopsies LABORATORY Drug Development Clinic Medical Oncologists Research Nursing Clinical Nursing Schedule tumor / Positive Solid Tumors / Solid Tumors / rare tumors / /

Organization

National Cancer Institute / Rare Tumors Initiative Center for Cancer Research National Cancer Institute NCI Rare Tumor Initiative / National Institutes of Health Clinical Center / Division of Cancer Treatment and Diagnosis National Cancer Institute Special / Early Clinical Trials Dev Office / Laboratory for Tissue Handling and Processing Data Managers Social Workers Pharmacists Laboratory for Pharmakinetic Analysis Clinical Trials / /

Person

Desmoid Tumors Shivaani Kummar / Abby B. Sandler / Rare Tumors / /

Position

Investigator / Assistant / Director / /

Product

sulindac / Z-Endoxifen / tamoxifen / PF03084014 / /

Technology

drug development / /

SocialTag